<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Procedure Volume Recovery Isn't The Only Trend: Q122 Total Joints Market Recap

6/9/22 9:30 AM

Q122 Total Joints Market Recap HeaderProcedure volume recovery is not the only trend on SmartTRAK’s radar

Procedure volume recovery continues to be a trend on everyone’s radar from industry execs to healthcare providers. In Q122, the Knee Replacement Market in the US seemed to experience a much stronger recovery than Hips based on YoY growth rates, according to SmartTRAK Financial Dashboard. However, Knees faced a much easier YoY comp as more knee procedures were postponed in Q121 compared to hips due to their more elective nature. Putting this into perspective, US Hip Market growth along with Knees reinforced the feeling that 2022 procedures will be closer to “normal” as the Total Joints Market recovers from the downsizing caused by COVID.  And, as the industry’s bandwidth for focusing on the pandemic decreases, the emphasis on other trends grows.

Among the many topics covered in detail in our comprehensive Q122 Total Joints Market Recap* are:

  • Complete Q122 Total Joints Market Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • Total Joints News including Revenues, Data, Charts and Shares
  • Targeting the ASC Site of Care
  • Cementless Knees Picking Up Speed
  • Hips Focusing on Anterior Approach
  • New Products in the Market
  • Q122 Regulatory Highlights

All eyes seem to be on the ambulatory surgery center (ASC) site of care for joint replacement. Most companies are investing resources to target the ASC market and some are already seeing results from these strategies.

Enovis*  formerly known as DJO Global prior to its split out from Colfax Corporation − plans to aggressively invest in its recon business including acquisitions focused on delivering outcomes that are a significant improvement over what’s currently available. No doubt their investment will also be used to support its growing presence in the ASC setting. During its Q122 earnings call, Enovis noted that ...

Read the entire Q122 Total Joints Market Recap including news, data, charts, company revenues, shares and our expert analysis*

*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.  Learn More

SmartTRAK has expanded it's coverage to include five new modules, including Pediatric Extremities and Trauma. Click to see details of all the exciting new additions to the SmartTRAK platform.


Lisa Mahan
Written by Lisa Mahan

20+ years' experience in orthopedic industry, including 12 years at J&J DePuy Orthopaedics. Competitive Intelligence Analyst and e-Marketing manager at J&J DePuy Orthopaedics.

    Follow Us on Social Media

    Recent Articles